| [16] Isolation of altered-function mutants and genetic suppressor elements of multidrug transporter P-glycoprotein by expression selection from retroviral libraries IB Roninson, D Zuhn, A Ruth, D de Graaf Methods in enzymology 292, 225-248, 1998 | 3 | 1998 |
| [25] Use of in-gel DNA renaturation for detection and cloning of amplified genes IB Roninson Academic Press 151, 332-371, 1987 | 24 | 1987 |
| 3-amino-4-[4-[4 (dimethylcarbamoyl) phenyl]-1, 4-diazepan-1-yl] thieno [2, 3-b] pyridine-2-carboxamide for use in cancer therapy and formulations comprising the same I Roninson, M Chen, J Li, J Liang, DC Porter, C McInnes US Patent App. 17/612,928, 2022 | | 2022 |
| 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation RJ Walter, AA Shtil, IB Roninson, O Holian Radiation research 147 (3), 369-375, 1997 | 45 | 1997 |
| 70 Highly sensitive procedure for detection of amplified DNA M Fukumoto, IB Roninson Cancer Genetics and Cytogenetics 28 (1), 46, 1987 | | 1987 |
| A combination of genetic suppressor elements produces resistance to drugs inhibiting DNA replication VVL Chernokhvostov, E Lausch, DJ Kirschling, EV Broude, IA Davidovich, ... Somatic Cell and Molecular Genetics 25, 9-26, 1999 | 46 | 1999 |
| A MOLECULAR MECHANISM FOR MULTIDRUG-RESISTANCE MM GOTTESMAN, MM CORNWELL, AT FOJO, D CLARK, K UEDA, ... IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY 23 (3), A63-A63, 1987 | | 1987 |
| A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses E Mechetner, IB Roninson | | 1993 |
| A selective and orally bioavailable quinoline-6-carbonitrile-based inhibitor of CDK8/19 mediator kinase with tumor-enriched pharmacokinetics L Zhang, C Cheng, J Li, L Wang, AA Chumanevich, DC Porter, A Mindich, ... Journal of medicinal chemistry 65 (4), 3420-3433, 2022 | 16 | 2022 |
| A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents BD Chang, EV Broude, M Dokmanovic, H Zhu, A Ruth, Y Xuan, ... Cancer research 59 (15), 3761-3767, 1999 | 734 | 1999 |
| A structural interpretation of the effect of GC-content on efficiency of RNA interference CY Chan, CS Carmack, DD Long, A Maliyekkel, Y Shao, IB Roninson, ... BMC bioinformatics 10, 1-7, 2009 | 115 | 2009 |
| A subunit of coatomer protein complex offers a novel tumor-specific target through a surprising mechanism M Shtutman, IB Roninson Autophagy 7 (12), 1551-1552, 2011 | 14 | 2011 |
| Abstract A043: CDK8/19-regulated transcriptional reprogramming: a druggable driver of castration-resistant prostate cancer J Li, T Hilimire, Y Liu, L Wang, J Liang, B Gyorffy, V Sikitzhytski, H Ji, ... Molecular Cancer Therapeutics 22 (12_Supplement), A043-A043, 2023 | | 2023 |
| Abstract LB-401: The chemosensitizing properties of iniparib in combination with DNA-damaging agents in the MDA-MB-468 (−) triple-negative breast cancer (TNBC) cell line V Ossovskaya, CU Lim, G Schools, S Kalurupalle, IB Roninson, E Broude Cancer Research 71 (8_Supplement), LB-401-LB-401, 2011 | 8 | 2011 |
| Abstract LB132: CDK8/19 inhibition overcomes in vitro and in vivo resistance to lapatinib in HER2+ breast cancer via STAT1 and STAT3 X Ding, AC Sharko, MSJ McDermott, H Ji, A Chumanevich, GP Schools, ... Cancer Research 81 (13_Supplement), LB132-LB132, 2021 | | 2021 |
| Abstract P3-07-05: CDK8 inhibition improves the efficacy of ER-and HER2-targeted drugs in breast cancer MS McDermott, A Chumanevich, J Liang, M Chen, S Altilia, C Hennes, ... Cancer research 77 (4_Supplement), P3-07-05-P3-07-05, 2017 | 1 | 2017 |
| Abstract P4-01-17: preventing adaptive therapeutic resistance to CDK4/6 inhibition with CDK8/19 inhibitors Z Mack, M Yastrebova, A Khamidullina, A Sharko, X Ding, S Bowe, ... Cancer Research 82 (4_Supplement), P4-01-17-P4-01-17, 2022 | 1 | 2022 |
| Abstract P4-15-13: CDK8 inhibition potentiates anti-ER and anti-HER2 therapies in breast cancer MS McDermott, C Lim, M Chen, A Chumanevich, JF Catroppo, B Gyorffy, ... Cancer Research 75 (9_Supplement), P4-15-13-P4-15-13, 2015 | | 2015 |
| Abstract P5-04-07: CDK8 protein complex as a potential biomarker and therapeutic target in breast cancer MSJ McDermott, B Györffy, AA Chumanevich, V Kaza, DC Porter, ... Cancer Research 76 (4_Supplement), P5-04-07-P5-04-07, 2016 | 1 | 2016 |
| Abstract P5-06-09: Cell Cycle Effects of Iniparib, a PARP Inhibitor, in Combination with Gemcitabine and Carboplatin in the MDA-MB-468 (-) Triple-Negative Breast Cancer (TNBC … V Ossovskaya, C Lim, G Schools, S Kalurupalle, IB Roninson, E Broude Cancer Research 70 (24_Supplement), P5-06-09-P5-06-09, 2010 | 3 | 2010 |
